删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments (2007)_香港中文大学

香港中文大学 辅仁网/2017-06-27

Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments
Publication in refereed journal


香港中文大学研究人员 ( 现职)
陈德章教授 (肿瘤学系)
陶谦教授 (肿瘤学系)


全文


引用次数
Scopushttp://aims.cuhk.edu.hk/converis/portal/Publication/182Scopus source URL

其它资讯

摘要Nasopharyngeal carcinoma (NPC) is a prevalent tumour in southern China and southeast Asia, particularly in the Cantonese population, where its incidence has remained high for decades. Recent studies have demonstrated that the aetiology of NPC is complex, involving multiple factors including genetic susceptibility, infection with the Epstein-Barr virus (EBV) and exposure to chemical carcinogens. During development of the disease, viral infection and multiple somatic genetic and epigenetic changes synergistically disrupt normal cell function, thus contributing to NPC pathogenesis. NPC is highly radiosensitive and chemosensitive, but treatment of patients with locoregionally advanced disease remains problematic. New biomarkers for NPC, including EBV DNA copy number or methylation of multiple tumour suppressor genes, which can be detected in serum and nasopharyngeal brushings, have been developed for the molecular diagnosis of this tumour. Meanwhile, new therapeutic strategies such as intensity-modulated radiation therapy and immuno- and epigenetic therapies might lead to more specific and effective treatments. ? Cambridge University Press 2007.

着者Tao Q., Chan A.T.C.
期刊名称Expert Reviews in Molecular Medicine
出版年份2007
月份5
日期1
卷号9
期次12
出版社Cambridge University Press
出版地United Kingdom
页次1 - 24
国际标準期刊号1462-3994
语言英式英语


相关话题/肿瘤 国际 香港中文大学 语言 英语